Abstract
First detected in African Burkitt’s lymphoma cells in 1964,1 the Epstein-Barr virus (EBV) was identified as the cause of infectious mononucleosis (IM) in 19682 when a laboratory worker developed antibodies to the virus during an episode of IM. Large-scale seroepidemiologic studies subsequently confirmed the role of EBV in IM. EBV has also been implicated as an etiologic factor in undifferentiated nasopharyngeal carcinoma, B cell lymphomas in immunocompromised individuals, and oral hairy leukoplakia.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet 1964; 1:702–3.
Henle G, Henle W, Diehl V. Relation of Burkitt’s tumour associated herpes-type virus to infectious mononucleosis. Proc Natl Acad Sci USA 1968;101:94–101.
Cohen JI. Molecular biology of Epstein-Barr virus and its mechanism of B-cell transformation. Ann Intern Med 1993; 118:48–50.
Biggar RJ, Henle W, Fleisher G, Bocker J, Lennette ET, Henle G. Primary Epstein-Barr virus infections in African infants. I. Decline of monoclonal antibodies and time of infection. Int J Cancer 1978;22:239–43.
Biggar RJ, Henle G, Bocker J, Lennette ET, Fleisher G, Henle W. Primary Epstein-Barr virus infections in African infants. II. Clinical and serological observations. Int J Cancer 1978; 22:244–50.
Hoagland RJ. Clinical manifestations. In: Infectious mononucleosis. Orlando, FL: Grune & Stratton, 1967:52–60.
Lambore S, McSherry J, Kraus A. Acute and chronic symptoms of mononucleosis. J Fam Pract 1991;33:33–7.
Hoagland RJ. General features of infectious mononucleosis. In: Glade PR, editor. Infectious mononucleosis. Philadelphia: Lippincott, 1973:3–4.
Straus SE. The chronic mononucleosis syndrome. J Infect Dis 1988;157:405–12.
Van der Horst C, Joncas J, Ahronheim G. Lack of effect of peroral acyclovir for the treatment of acute infectious mononucleosis. J Infect Dis 1991;164:788–92.
Morgan AJ, Allison AC, Finerty S, et al. Validation of first-generation Epstein-Barr virus vaccine preparation suitable for human use. J Med Virol 1989;29:74–8.
Durbin WA, Sullivan JL. Epstein-Barr virus infections. Pedi-atr Rev 1994(2);15:63–8.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
McSherry, J. (1998). Epstein-Barr Virus Infection and Infectious Mononucleosis. In: Taylor, R.B., David, A.K., Johnson, T.A., Phillips, D.M., Scherger, J.E. (eds) Family Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-2947-4_38
Download citation
DOI: https://doi.org/10.1007/978-1-4757-2947-4_38
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4757-2949-8
Online ISBN: 978-1-4757-2947-4
eBook Packages: Springer Book Archive